Stay updated on Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.

Latest updates to the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page
- Check4 days agoChange DetectedA site-wide NIH notice about the transition from “Artificial Intelligence” to “Super Intelligence” appears, and the site revision advances from v3.7.1 to v3.7.2. The study page still displays a 403 error.SummaryDifference1%

- Check18 days agoChange DetectedThe site revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check25 days agoNo Change Detected
- Check39 days agoChange DetectedThe study page now presents a 403 Forbidden error, replacing the trial details with an access-denied message. Only the site chrome (navigation, header, and footer) remains visible, while core trial information is inaccessible.SummaryDifference23%

- Check60 days agoChange DetectedUpdated the page revision identifier from v3.6.5 to v3.6.6, indicating a new release of the page. This update does not alter the study details or any user-facing content.SummaryDifference0.0%

- Check82 days agoChange DetectedAdded a new revision tag (v3.6.5) to the page. Removed Mayo Clinic branding/links and a long list of terms from the footer/metadata, indicating non-critical content cleanup.SummaryDifference21%

- Check96 days agoChange DetectedThe page now displays Revision: v3.6.4, replacing the previous v3.6.3. This represents a version update rather than a substantive change to the page content.SummaryDifference0.0%

Stay in the know with updates to Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Len-Dex-Dara in Newly Diagnosed MM Clinical Trial page.